Table 2. Unadjusted and age- and sex- adjusted percentages (95% CIs) of deaths by cause and eGFR strata.
| Death attributed to | ||||
|---|---|---|---|---|
| eGFR strata | CVD | Cancer | Infection | Other |
| >90 ml/min/1.73 m2 | ||||
| Unadjusted | 17.3 (16.7 to 18.0) | 51.9 (51.0 to 52.7) | 3.2 (2.9 to 3.5) | 27.7 (26.9 to 28.4) |
| Age/sex adjusted | 21.2 (20.3 to 22.0) | 46.6 (45.6 to 47.6) | 3.5 (3.2 to 3.9) | 28.7 (27.8 to 29.6) |
| 60–89 ml/min/1.73 m2 | ||||
| Unadjusted | 34.7 (34.3 to 35.2) | 31.8 (31.3 to 32.4) | 4.3 (4.1 to 4.5) | 29.2 (28.6 to 29.7) |
| Age/sex adjusted | 33.5 (33.0 to 34.1) | 32.7 (32.2 to 33.3) | 4.3 (4.0 to 4.5) | 29.5 (29.0 to 30.0) |
| 45–59 ml/min/1.73 m2 | ||||
| Unadjusted | 42.6 (41.8 to 43.5) | 24.6 (23.8 to 25.4) | 5.3 (4.9 to 5.7) | 27.4 (26.7 to 28.2) |
| Age/sex adjusted | 40.8 (39.9 to 41.7) | 26.0 (25.2 to 26.8) | 5.3 (4.9 to 5.7) | 27.8 (27.0 to 28.7) |
| 30–44 ml/min/1.73 m2 | ||||
| Unadjusted | 46.6 (45.7 to 47.6) | 20.3 (19.5 to 21.1) | 5.9 (5.4 to 6.4) | 27.2 (26.3 to 28.1) |
| Age/sex adjusted | 44.7 (43.7 to 45.7) | 21.6 (20.8 to 22.5) | 5.9 (5.4 to 6.4) | 27.7 (26.8 to 28.6) |
| 15–29 ml/min/1.73 m2 | ||||
| Unadjusted | 47.6 (46.2 to 48.9) | 18.5 (17.4 to 19.5) | 5.6 (5.0 to 6.2) | 28.4 (27.2 to 29.6) |
| Age/sex adjusted | 45.8 (44.5 to 47.2) | 19.6 (18.5 to 20.7) | 5.6 (5.0 to 6.2) | 29.0 (27.7 to 30.0) |
| ESRD | ||||
| Unadjusted | 39.7 (37.4 to 42.0) | 14.2 (12.5 to 15.8) | 5.1 (4.0 to 6.1) | 41.0 (38.7 to 43.4) |
| Age/sex adjusted | 38.9 (36.5 to 41.2) | 14.2 (12.6 to 15.9) | 5.0 (4.0 to 6.0) | 41.9 (39.6 to 44.3) |
| Total (cases) | 25216 | 21941 | 3250 | 20140 |
CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.